GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a prominent focus in therapeutic studies, largely due to its impressive impact on managing conditions such as second type diabetes and weight gain. Ongoing trials have shown that in addition to glucose control, GLP-1 agonists offer potential for heart well-being and p